Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Grifols
Sort By
Newest First
1 / 2
New CDMO Facility
Leveraging a State-of-the-Art CDMO Facility to Advance Healthcare
Grifols
PAO-02-23-PATV-04
Feb 23, 2023
Parenteral Drug Products
Innovating to Optimize Quality in Injectable Drugs
Michael Howell
Grifols
PAO-11-022-CL-16
Jan 12, 2023
Araclon Biotech
Alzheimer's Vaccine
Araclon Biotech Advances in Its Innovative Vaccine and Diagnostic Test for Alzheimer's
Araclon Biotech
PR-M03-22-06
Mar 15, 2022
Parenteral Manufacturing
Staying Ahead of Trends in Small-Volume Parenteral Manufacturing
Marga Viñes; Oriol Prat; Oriol Argemi
Grifols
PAO-01-22-R250-08
Jan 28, 2022
Recombinant Proteins
Meeting the Renewed Demand for Microbial Protein Production
Grifols Recombinant Protein CDMO
PAO-01-22-R250-07
Jan 28, 2022
Parenteral Drugs
A CDMO Dedicated to Supporting Small-Volume, Small-Molecule Parenteral Projects
Marga Viñes; Oriol Prat; Oriol Argemi
Grifols
PAO-12-21-CL-02
Dec 13, 2021
Grifols
Hyperimmunes
GigaGen Publishes Research on Company’s Recombinant Hyperimmunes in Nature Biotechnology
Grifols
PR-M04-21-018
Apr 19, 2021
Grifols
Acquisition
Grifols Reinforces its Innovation Strategy After Completing the Acquisition of GigaGen to Boost a Novel Method to Generate a Wide Range of Immunoglobulins
Grifols
PR-M11-20-045
Mar 09, 2021
Parenterals
Trends Shaping the Dynamic Market for Parenterals
Marga Viñes
Grifols
PAP-Q3-20-CL-018
Sep 29, 2020
Continuous Improvement
The Critical Role of Continuous Improvement in Parenteral Drug Manufacturing
Antonio A. Gomez
Grifols
PAP-Q1-20-CL-010
Mar 19, 2020
Orphan Drugs
Customer Engagement and Information Sharing are Essential for Success in Orphan Drug Outsourcing
Marga Viñes
Grifols
PAP-Q3-19-CL-013
Oct 29, 2019
Grifols
FDA Approval
Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies
Grifols
PR-M07-19-NI-018
Jul 09, 2019
Parenteral Manufacturing
Catering to a Growing Demand for Small-Volume Parenteral Manufacturing
Oriol Prat
Grifols
PAO-M04-19-CL-001
May 28, 2019
Parenteral Solutions
Supporting Small and Emerging Pharma through Collaboration and Specialized Expertise
Marga Viñes
Grifols
PAP-Q2-2019-CL-017
May 24, 2019
Form-Fill-Seal
Investing in Form-Fill-Seal Technology
Lluc Mercadé
Grifols
PAP-Q1-2019-CL-011
Apr 12, 2019
Grifols
Facility Opening
Grifols Announces the Opening of its new Plasma Donor Center in Russellville, AR
Grifols
PR-M03-19-NI-082
Mar 28, 2019
Grifols
FDA Approval
Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System
Grifols
PR-M02-19-NI-017
Feb 08, 2019
Quality
Continuous Quality is Essential in Parenteral Manufacturing
Marta Serra
Grifols
PAO-M12-18-CL-003
Dec 19, 2018
Grifols
FDA Approval
FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing
Grifols
PR-M10-18-NI-047
Oct 15, 2018
Terminal Sterilization
Terminal Sterilization for Parenteral Drugs: Finding the Right CDMO Partner
Lluis Twose
Grifols
PAP-Q3-18-CL-015
Oct 02, 2018
1 / 2
